Related references
Note: Only part of the references are listed.Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex
Pascal Fossat et al.
CEREBRAL CORTEX (2012)
Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia
Andrea de Bartolomeis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Mark J. Millan et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex
Darrick T. Balu et al.
NEUROBIOLOGY OF DISEASE (2012)
Contributions of the D-serine pathway to schizophrenia
Viviane Labrie et al.
NEUROPHARMACOLOGY (2012)
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
D-Serine: The right or wrong isoform?
Sabine A. Fuchs et al.
BRAIN RESEARCH (2011)
Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
Surendra P. Singh et al.
CNS DRUGS (2011)
Is rat an appropriate animal model to study the involvement of d-serine catabolism in schizophrenia? insights from characterization of d-amino acid oxidase
Luca F. Frattini et al.
FEBS JOURNAL (2011)
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
L. M. DeVito et al.
GENES BRAIN AND BEHAVIOR (2011)
Is sarcosine a biomarker for prostate cancer?
Haleem J. Issaq et al.
JOURNAL OF SEPARATION SCIENCE (2011)
Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
Mao Horio et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Localization of D-serine and serine racemase in neurons and neuroglias in mouse brain
Xiaohui Ding et al.
NEUROLOGICAL SCIENCES (2011)
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain
Christine A. Strick et al.
NEUROPHARMACOLOGY (2011)
The Association of Schizophrenia Risk D-Amino Acid Oxidase Polymorphisms With Sensorimotor Gating, Working Memory and Personality in Healthy Males
Panos Roussos et al.
NEUROPSYCHOPHARMACOLOGY (2011)
N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice
David-Marian Otte et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Effects of low-dose d-serine on recognition and working memory in mice
Patricia Bado et al.
PSYCHOPHARMACOLOGY (2011)
Inhibition of D-Amino Acid Oxidase Activity by Antipsychotic Drugs Evaluated by a Fluorometric Assay Using D-Kynurenine as Substrate
Sumiko Iwasa et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2011)
The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice
Jordan E. Antflick et al.
AMINO ACIDS (2010)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
Glycine transport accounts for the differential role of glycine vs. d-serine at NMDA receptor coagonist sites in the salamander retina
Eric R. Stevens et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
Hsien-Yuan Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
R. M. Abou El-Magd et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
L. Verrall et al.
MOLECULAR PSYCHIATRY (2010)
Testing the glutamate hypothesis of schizophrenia
Joshua A. Gordon
NATURE NEUROSCIENCE (2010)
The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia
Viviane Labrie et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Olfactory Dysfunction in Schizophrenia: A Review of Neuroanatomy and Psychophysiological Measurements
An D. Nguyen et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2009)
Behavioral changes in G72/G30 transgenic mice
David M. Otte et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Viviane Labrie et al.
HUMAN MOLECULAR GENETICS (2009)
Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent D-Amino Acid Oxidase (DAAO) Inhibitors
Allen J. Duplantier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
Gregor Habl et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Potential pathophysiological role of d-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain
Koji Ono et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Functional and Immunocytochemical Characterization of D-Serine Transporters in Cortical Neuron and Astrocyte Cultures
Zongjun Shao et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
The Behavioral and Neurochemical Effects of a Novel D-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and D-Serine
Sean M. Smith et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
A. C. Basu et al.
MOLECULAR PSYCHIATRY (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe
Andreas Jansen et al.
NEUROIMAGE (2009)
DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study
Erik G. Jonsson et al.
NEUROPSYCHOBIOLOGY (2009)
Feedback inactivation of D-serine synthesis by NMDA receptor-elicited translocation of serine racemase to the membrane
Livia Balan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia
Tohru Ohnuma et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
Jun-Ichi Karasawa et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Sarcosine (N-Methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2008)
Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia
Jeremy Hall et al.
BIOLOGICAL PSYCHIATRY (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors
Tim Sparey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Investigation of G72 (DAOA) expression in the human brain
Isabel Benzel et al.
BMC PSYCHIATRY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine
Kenji Hashimoto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients
Sabine A. Fuchs et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
In vitro and in vivo pharmacological profile of AS057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties
Tiziana Adage et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility
Silvia Sacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Disposition of D-serine in healthy adults
Guochuan E. Tsai et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Synthesis and biological evaluation of D-amino acid oxidase inhibitors
Dana Ferraris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction
Elisabet Vilella et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area
Lilly Schwieler et al.
LIFE SCIENCES (2008)
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
Nicole C. Allen et al.
NATURE GENETICS (2008)
Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior:: A search for a new developmental model of schizophrenia
K. Wedzony et al.
NEUROSCIENCE (2008)
NMDA Antagonist and Antipsychotic Actions in Cortico-subcortical Circuits
Lucila Kargieman et al.
NEUROTOXICITY RESEARCH (2008)
Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)
Tohru Ohnuma et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Glycine and D-serine, but not D-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801
Nobuhisa Kanahara et al.
PSYCHOPHARMACOLOGY (2008)
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
Viviane Labrie et al.
PSYCHOPHARMACOLOGY (2008)
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
Alice Egerton et al.
PSYCHOPHARMACOLOGY (2008)
Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes
Jiajun Shi et al.
SCHIZOPHRENIA RESEARCH (2008)
Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia
P. W. J. Burnet et al.
SCHIZOPHRENIA RESEARCH (2008)
Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance
Carolin Opgen-Rhein et al.
SCHIZOPHRENIA RESEARCH (2008)
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Caroline Madeira et al.
SCHIZOPHRENIA RESEARCH (2008)
Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function
M. Kvajo et al.
MOLECULAR PSYCHIATRY (2008)
Neuroplasticity of neocortical circuits in schizophrenia
David A. Lewis et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample
A. Corvin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
Louise Verrall et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Significant support for DAO as a schizophrenia susceptibility locus: Examination of five genes putatively associated with schizophrenia
Linda S. Wood et al.
BIOLOGICAL PSYCHIATRY (2007)
A genetic variant of the serine racemase gene is associated with schizophrenia
Yukitaka Morita et al.
BIOLOGICAL PSYCHIATRY (2007)
Brain derived neurotropic factor in first-episode psychosis
Peter F. Buckley et al.
SCHIZOPHRENIA RESEARCH (2007)
Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating D-serine reuptake in the mouse CNS
A. Richard Rutter et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation
Asif K. Mustafa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample
Jana Strohmaier et al.
PSYCHIATRIC GENETICS (2007)
No association of G72 and D-amino acid oxidase genes with schizophrenia
Yu-Li Liu et al.
SCHIZOPHRENIA RESEARCH (2006)
Psychosis pathways converge via D2High dopamine receptors
Philip Seeman et al.
SYNAPSE (2006)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
The G72/G30 gene complex and cognitive abnormalities in schizophrenia
Terry E. Goldberg et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, D-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)
Ranjna Kapoor et al.
BRAIN RESEARCH (2006)
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia
S. L. Almond et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Serine racemase protein expression in cortex and hippocampus in schizophrenia
Amy E. Steffek et al.
NEUROREPORT (2006)
Glutamate and schizophrenia: Beyond the dopamine hypothesis
Joseph T. Coyle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Glia-derived D-serine controls NMDA receptor activity and synaptic memory
Aude Panatier et al.
CELL (2006)
Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia
AY Goltsov et al.
MOLECULAR PSYCHIATRY (2006)
Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells
K Shoji et al.
NEUROSCIENCE LETTERS (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Regulation of serine racemase activity by D-serine and nitric oxide in human glioblastoma cells
K Shoji et al.
NEUROSCIENCE LETTERS (2006)
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients
Aitor Palomino et al.
SCHIZOPHRENIA RESEARCH (2006)
Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios
MD Fallin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Preferred stereoselective brain uptake of D-serine -: a modulator of glutamatergic neurotransmission
[Anonymous]
NUCLEAR MEDICINE AND BIOLOGY (2005)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Sensitive determination of D-amino acids in mammals and the effect of D-amino-acid oxidase activity on their amounts
K Hamase et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice
XM Xie et al.
BRAIN RESEARCH (2005)
Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo
RA Bressan et al.
BIOLOGICAL PSYCHIATRY (2005)
D-amino acids in the central nervous system in health and disease
SA Fuchs et al.
MOLECULAR GENETICS AND METABOLISM (2005)
No changes in serum epidermal growth factor levels in patients with schizophrenia
K Hashimoto et al.
PSYCHIATRY RESEARCH (2005)
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels
K Yamada et al.
BIOLOGICAL PSYCHIATRY (2005)
Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia
T Lipina et al.
PSYCHOPHARMACOLOGY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task
V Laurent et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder
J Schumacher et al.
MOLECULAR PSYCHIATRY (2004)
Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis
M Korostishevsky et al.
BIOLOGICAL PSYCHIATRY (2004)
Characterization and localization of a human serine racemase
MH Xia et al.
MOLECULAR BRAIN RESEARCH (2004)
Association of DAAO with schizophrenia in the Chinese population
XM Liu et al.
NEUROSCIENCE LETTERS (2004)
Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain
L Helboe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
I Chumakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
D-cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia
AE Evins et al.
SCHIZOPHRENIA RESEARCH (2002)
A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes
DC Javitt et al.
BRAIN RESEARCH (2002)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts
CB Willmore et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino-acid oxidase activity
A Morikawa et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2001)
N-methyl-D-aspartate receptors and information processing:: human choice reaction time under a subanaesthetic dose of ketamine
Y Guillermain et al.
NEUROSCIENCE LETTERS (2001)
Cloning and characterization of a human brain Na+-independent transporter for small neutral amino acids that transports D-serine with high affinity
J Nakauchi et al.
NEUROSCIENCE LETTERS (2000)
Identification and characterization of a Na+-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids
Y Fukasawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)